As the U.S. midterm elections draw closer, yet another poll finds that Americans remain very concerned about prescription drug pricing and are unhappy with how Washington is trying to resolve the issue.
Specifically, 77 percent regard drug costs as unreasonable and 65 percent report they are extremely or very concerned about prices, according to a poll of 1,022 adults Americans that was conducted last month by a pair of nonprofit research groups, the West Health Institute and NORC at the University of Chicago.
Not surprisingly, these concerns are reflected in responses about Washington. Just 23 percent approve of what President Trump is doing to lower costs, even though his administration is trying to develop and implement a blueprint. Similarly, only 20 percent approve of what Democrats in Congress are doing and 16 percent approve of how Republicans are handling the problem.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
